Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 444,635 | 237,689 | 1,442,232 | 1,079,306 | 703,724 |
| Depreciation Amortization | 895,745 | 470,154 | 1,920,971 | 1,399,201 | 944,322 |
| Income taxes - deferred | -67,194 | -10,431 | 79,574 | -15,127 | -44,357 |
| Accounts receivable | -24,356 | -321,006 | -193,078 | -105,985 | -251,288 |
| Accounts payable and accrued liabilities | -30,055 | -181,446 | 23,302 | -6,769 | 4,749 |
| Other Working Capital | -276,322 | -457,520 | -115,669 | 42,027 | 2,381 |
| Other Operating Activity | 26,087 | 440,651 | -212,007 | -245,977 | 524 |
| Operating Cash Flow | $968,539 | $178,090 | $2,945,325 | $2,146,676 | $1,360,055 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -350,274 | -179,388 | -981,897 | -661,807 | -458,072 |
| Net Acquisitions | -22,289 | -24,987 | -451,621 | -316,043 | -152,813 |
| Purchase Of Investment | -91,316 | -47,879 | -152,716 | -73,865 | -75,086 |
| Sale Of Investment | 28,633 | 15,115 | 170,977 | 139,677 | 115,838 |
| Investing Cash Flow | $-435,245 | $-237,139 | $-1,415,257 | $-912,038 | $-570,132 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 683,295 | 202,290 | 2,134,557 | 2,088,988 | 2,012,800 |
| Debt Issued | 264,286 | 261,879 | 1,471,888 | 1,452,487 | 1,482,155 |
| Debt Repayment | -762,347 | -718,307 | -2,464,397 | -2,437,675 | -2,461,354 |
| Common Stock Issued | 21,438 | 889 | 7,703 | 7,081 | 6,299 |
| Dividend Paid | -568,884 | N/A | -860,468 | -757,801 | -664,787 |
| Other Financing Activity | -696,573 | -45,975 | -1,501,230 | -1,139,428 | -830,950 |
| Financing Cash Flow | $-1,058,785 | $-299,225 | $-1,211,946 | $-786,348 | $-455,837 |
| Exchange Rate Effect | 39,170 | 12,285 | 155,256 | 118,075 | 59,216 |
| Beginning Cash Position | 1,576,777 | 1,662,713 | 1,279,569 | 1,275,351 | 1,303,146 |
| End Cash Position | 1,090,456 | 1,316,724 | 1,752,946 | 1,841,715 | 1,696,449 |
| Net Cash Flow | $-486,321 | $-345,989 | $473,377 | $566,364 | $393,302 |
| Free Cash Flow | |||||
| Operating Cash Flow | 968,539 | 178,090 | 2,945,325 | 2,146,676 | 1,360,055 |
| Capital Expenditure | -355,727 | -181,893 | -1,010,793 | -693,603 | -474,319 |
| Free Cash Flow | 612,812 | -3,803 | 1,934,532 | 1,453,073 | 885,737 |